A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT07551999
- Status
- Recruiting
Conditions
- Chronic Fatigue Syndrome
- Encephalomyelitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Voice Recording — OTHERPatients will create 5 - 10 minute voice recordings that include counting, vowel prolongation, alternating speed, and word repetition, every 2 weeks, for a total of 12 weeks. Recordings will be collected using the Visible mobile application, and patients will wear the Visible Armband 2.0 while recording.
Study Details
The purpose of this research is to evaluate the use of a voice-based tool in the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Key Dates
- First listed
- Apr 27, 2026
- Start date
- May 26, 2026
- Status verified
- May 2026
- Primary completion
- Dec 31, 2027
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
Arms
- Arm: Patients diagnosed with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Primary Outcome Measure
Feasibility of Mayo Speech Test (Voice Signatures) for Screening of ME/CFS [ Time Frame: 12 weeks ]
Central Contacts
- Katie Cruz507-284-5404
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | Stephanie L. Grach, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site
Related Studies
- Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.PHASE1 · Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- The Long COVID-19 Wearable Device StudyRecruiting · Scripps Translational Science Institute · La Jolla, California
- Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study ExperiencesNot Yet Recruiting · Power Life Sciences Inc. · San Francisco, California
- Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue SyndromePHASE1/PHASE2 · Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York